KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Debt Ratio (2016 - 2024)

Biomarin Pharmaceutical (BMRN) has disclosed Debt Ratio for 12 consecutive years, with 0.07 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Debt Ratio changed N/A year-over-year to 0.07, compared with a TTM value of 0.07 through Jun 2024, changed N/A, and an annual FY2023 reading of 0.07, changed N/A over the prior year.
  • Debt Ratio was 0.07 for Q2 2024 at Biomarin Pharmaceutical, down from 0.07 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.07 in Q4 2023 and bottomed at 0.0 in Q3 2022.
  • Average Debt Ratio over 5 years is 0.03, with a median of 0.01 recorded in 2022.
  • The sharpest move saw Debt Ratio surged 2670.44% in 2020, then tumbled 86.74% in 2021.
  • Year by year, Debt Ratio stood at 0.06 in 2020, then crashed by 86.78% to 0.01 in 2021, then tumbled by 43.75% to 0.0 in 2022, then surged by 1497.65% to 0.07 in 2023, then dropped by 3.0% to 0.07 in 2024.
  • Business Quant data shows Debt Ratio for BMRN at 0.07 in Q2 2024, 0.07 in Q1 2024, and 0.07 in Q4 2023.